INTERACCION CON OTROS PRODUCTOS: No se han descrito
Low cortisol level (e.g., 3 microunits/ml (21 pM) in the context of hypoglycemia suggests pathologically excessive insulin levels, with the following differential diagnosis: Exogenous insulin (unfortunately, not all are detected by the assay for example, glargine may be missed)
Glycemic outcomes (HbA1c reduction) and weight outcomes both showed dose-dependent responses (PMID 37385280)
VEGAN DELAYED-RELEASE CAPSULES: The delayed-release technology protects the active ingredients from stomach acid, allowing them to be gradually released in the intestine
[1] Lactobacillus plantarum is well studied for intestinal barrier support and metabolic markers, and Lactobacillus fermentum , the genus behind the GLP-1-drug synergy study [6] , rounds out this group
While its stable at room temperature for several weeks, long term storage requires -20C